DNARx has a total of 12 patent applications. Its first patent ever was published in 2016. It filed its patents most often in United States, EPO (European Patent Office) and China. Its main competitors in its focus markets biotechnology, pharmaceuticals and organic fine chemistry are SUZHOU PULUODA BIOLOGICAL SCIENCE AND TECH CO LTD, SAMSUNG BIOEPIS CO LTD and VIROMETIX AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | China | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Organic fine chemistry | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Enzymes | |
#5 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Heath Timothy D | 12 |
#2 | Debs Robert James | 12 |
#3 | Handumrongkul Chakkrapong | 12 |
Publication | Filing date | Title |
---|---|---|
EP3600428A1 | Systems and methods for nucleic acid expression in vivo | |
EP3808340A1 | Systems and methods for nucleic acid expression in vivo |